本頁面由Tiger Trade Technology Pte. Ltd.提供服務

傳奇生物

18.16
-0.0400-0.22%
盤後18.160.00000.00%19:53 EDT
成交量:218.29萬
成交額:3,947.69萬
市值:33.54億
市盈率:-11.21
高:18.29
開:18.17
低:17.76
收:18.20
52周最高:45.30
52周最低:16.24
股本:1.85億
流通股本:8,138.20萬
量比:1.51
換手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-1.6200
每股收益(LYR):-1.6200
淨資產收益率:-29.06%
總資產收益率:-5.01%
市淨率:3.35
市盈率(LYR):-11.21

資料載入中...

2022/09/30

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/09

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/06/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/29

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/13

招股説明書

F-1 - Registration statement for certain foreign private issuers